Geode Capital Management, LLC Nanobiotix S.A. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Nanobiotix S.A. stock. As of the latest transaction made, Geode Capital Management, LLC holds 10,184 shares of NBTX stock, worth $75,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,184
Previous 10,184
-0.0%
Holding current value
$75,361
Previous $36,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NBTX
# of Institutions
11Shares Held
5.88MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$41.6 Million8.95% of portfolio
-
Black Rock Inc. New York, NY239KShares$1.77 Million0.0% of portfolio
-
Morgan Stanley New York, NY5.3KShares$39,2200.0% of portfolio
-
Ubs Group Ag4.42KShares$32,6930.0% of portfolio
-
Ever Source Wealth Advisors, LLC517Shares$3,8250.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $258M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...